JoynCare drops over 10% amid CRO sector weakness
JoynCare (6127.HK) tumbled more than 10% to HK$23.42 during regular trading.
The decline came as Hong Kong pharmaceutical stocks slid broadly, with CRO concepts leading losses. WuXi AppTec dropped over 8% and Pharmaron declined more than 7%, dragging sentiment across the sector.